The life expectancy and average age of persons with multiple sclerosis (MS) have increased
significantly during the last two decades. The introduction of disease-modifying therapies …

Background Aerobic capacity (VO 2max) is a strong health and performance predictor and is
regarded as a key physiological measure in the healthy population and in persons with …

Background The role that dietary interventions can play in multiple sclerosis (MS)
management is of huge interest amongst patients and researchers but data evaluating this is …

Abstract Purpose of Review Multiple sclerosis (MS) is an autoimmune disorder of the central
nervous system that can lead to severe physical, cognitive, and neurological deficits that …

The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new disease-modifying …

Multiple sclerosis (MS), a chronic inflammatory disease of unknown etiology, involves an
immunemediated attack of the central nervous system (CNS) that produces demyelination …

Multiple sclerosis is a chronic autoimmune disease of the central nervous system that results
in varying degrees of disability. Progressive multiple sclerosis, characterized by a steady …

Background Fracture nonunion risk is related to severity of injury and type of treatment, yet
fracture healing is not fully explained by these factors alone. We hypothesize that patient …

Background Individuals with multiple sclerosis (MS) report fatigue, pain, depression,
cognitive difficulties, and other symptoms. It is often difficult to compare symptoms across …

Background: Few studies have assessed the accuracy of administrative data for identifying
multiple sclerosis (MS) patients. Objectives: To validate administrative data algorithms for …